Treatment of REM sleep behavior disorder with donepezil: A report of three cases
Abstract
Article abstract Three patients with REM behavior disorder whose nocturnal symptoms were markedly improved by treatment with the acetylcholinesterase inhibitor donepezil are reported. Donepezil may have a role in the treatment of REM behavior disorder, possibly through its actions on cholinergic pathways in the brainstem.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Schenk CH, Mahowald MR. REM sleep parasomnias. Neurol Clin . 1996; 14: 697–720.
2.
Shiromani PJ, Gillin JC, Henriksen SJ. Acetylcholine and the regulation of REM sleep: basic mechanisms and clinical implications for affective illness and narcolepsy. Ann Rev Pharmacol Toxicol . 1987; 27: 137–156.
3.
Jones BE. The organization of central cholinergic systems and their functional importance in sleep-waking states. Prog Brain Res . 1993; 98: 61–71.
4.
Ringman JM, Cummings JL. Treatment of parasomnia with donepezil. J Neuropsychiatry Clin Neurosci . 1999; 11: P 29.Abstract.
5.
Boeve BF, Silber MH, Ferman TJ, et al. REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease. Neurology . 1998; 51: 363–370.
6.
American Sleep Disorders Association. REM sleep behavior disorder. In: The International Classification of Sleep Disorders. Rochester, MN: ASDA, 1990: 177–180.
7.
Rye DB. Contributions of the pedunculopontine region to normal and altered REM sleep. Sleep . 1997; 20: 757–788.
8.
Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson’s disease with therapeutic response to levodopa. Mov Disord . 1996; 11: 214–216.
9.
Holsboer-Trachsler E, Hatzinger M, et al. Effects of the novel acetylcholinesterase inhibitor SDZ ENA 713 on sleep in man. Neuropsychopharmacology . 1993; 8: 87–92.
10.
Carlander B, Touchon J, Ondze B, Billiard M. REM sleep behavior disorder induced by cholinergic treatment in Alzheimer’s disease. J Sleep Res . 1996; 5 (suppl 1): 28.
Information & Authors
Information
Published In
Copyright
© 2000.
Publication History
Received: March 1, 1999
Accepted: May 10, 2000
Published online: September 26, 2000
Published in print: September 26, 2000
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Pharmacological and non-pharmacological management of sleep disturbances in Parkinson’s disease: if when and how, Expert Opinion on Pharmacotherapy, 25, 16, (2135-2149), (2024).https://doi.org/10.1080/14656566.2024.2422004
- Management of REM sleep behavior disorder: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment, Journal of Clinical Sleep Medicine, 19, 4, (769-810), (2023).https://doi.org/10.5664/jcsm.10426
- Parkinson’s Disease: A Narrative Review on Potential Molecular Mechanisms of Sleep Disturbances, REM Behavior Disorder, and Melatonin, Brain Sciences, 13, 6, (914), (2023).https://doi.org/10.3390/brainsci13060914
- Considering REM Sleep Behavior Disorder in the Management of Parkinson’s Disease, Nature and Science of Sleep, Volume 15, (333-352), (2023).https://doi.org/10.2147/NSS.S266071
- New Paradigm in the Management of REM Sleep Behavior Disorder, Current Sleep Medicine Reports, 9, 1, (23-34), (2023).https://doi.org/10.1007/s40675-023-00248-7
- Sleep disorders in Lewy body dementia: Mechanisms, clinical relevance, and unanswered questions, Alzheimer's & Dementia, 19, 11, (5264-5283), (2023).https://doi.org/10.1002/alz.13350
- Diagnosis and treatment of sleep disorders: a brief review for clinicians, Dialogues in Clinical Neuroscience, 5, 4, (371-388), (2022).https://doi.org/10.31887/DCNS.2003.5.4/vabad
- Sleep-wake mechanisms and drug discovery: sleep EEG as a tool for the development of CNS-acting drugs, Dialogues in Clinical Neuroscience, 4, 4, (342-350), (2022).https://doi.org/10.31887/DCNS.2002.4.4/lstaner
- Drugs Used in Parasomnia, Sleep Medicine Clinics, 17, 3, (367-378), (2022).https://doi.org/10.1016/j.jsmc.2022.06.004
- The association of changes of sleep architecture related to donepezil: A systematic review and meta-analysis, Journal of the Formosan Medical Association, 121, 8, (1466-1477), (2022).https://doi.org/10.1016/j.jfma.2021.10.013
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.